by Backoffice | Jan 23, 2024 | Collaborations
Cell2Cure has January 2024 received a significant equity investment from Endeavour Cell ApS, to further develop our collaboration. Endeavour Cells will own 51% of the company. In addition to the invested capital the collaboration with Endeavor Cells includes milestone...
by Backoffice | Jan 4, 2024 | Collaborations
In Europe, approximately 30 million people suffer from blindness and visual impairment. Rare Eye Diseases are a major cause that can result in blindness in children and young adults and affect adults and the ageing population. Current management is expensive, has low...
